This webcast is intended to improve care of patients with prostate cancer by accelerating adoption of new guidelines and evidence-based practice change.
A review of current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
Atrial fibrillation (AF) is associated with a 4- to 5-fold increase in the risk for ischemic stroke and systemic embolism, yet less than one-half of patients with AF undergo appropriate risk stratification and anticoagulant therapy.
Among the many issues clinicians face today, staying current with advances in medicine is becoming a major challenge. Teaching Brief® articles will allow clinicians to stay up-to-date and assimilate new information into their daily practice. The content of these Teaching Brief® articles has been validated through an independent expert peer review process.
Endovascular therapy is an area of intense investigation and recent data showing the benefits of this therapy for stroke represent a paradigm shift. This educational activity will feature the results of several randomized clinical trials comparing the administration of tissue plasminogen activator (tPA) followed by device removal of a clot with IV tPA alone and how to identify which patients may benefit from endovascular therapy. Experts will also touch upon the implications of these trials on emergency medical services and how we may optimize institutional systems of care for better patient outcomes.